NewslettersCancer Stem Cell NewsHuman Immunology News Malignant A-to-I RNA Editing by ADAR1 Drives T Cell Acute Lymphoblastic Leukemia Relapse via Attenuating dsRNA Sensing By Noshin Noorjahan - January 31, 2024 0 Researchers showed that the RNA-editing enzyme ADAR1 was a crucial stemness factor that promotes leukemia-initiating cell self-renewal by attenuating aberrant double-stranded RNA sensing. [Cell Reports] Full ArticleGraphical Abstract